|
21 Dec 2010 |
Amorcyte Stem Cell Therapy Demonstrates Clinically Significant Reperfusion in Severe Heart Attack Patients
|
|
21 Dec 2010 |
Isis Initiates Phase 1 Clinical Trial of ISIS-APOCIIIRx to Treat Hypertriglyceridemia
|
|
20 Dec 2010 |
Idera Pharmaceuticals Announces Preliminary Data from Phase 1 Clinical Trial of IMO-2125 in Treatment-Naïve Genotype 1 HCV Patients
|
|
20 Dec 2010 |
Fibrocell Science, Inc. Submits Complete Response to FDA Regarding Azficel-T
|
|
20 Dec 2010 |
Cardio3 BioSciences Announces Significant Progress in its Programme for the Treatment of Acute Myocardial Infarction
|
|
17 Dec 2010 |
RXi Pharmaceuticals Nominates Dermal Anti-Scarring RNAi Product Candidate to Advance into Development
|
|
16 Dec 2010 |
Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-594 in Patients With Refractory Metastatic Colorectal Cancer
|
|
15 Dec 2010 |
Evotec Announces Metabolic Disease Alliance With MedImmune
|
|
13 Dec 2010 |
EGEN Announces that Phase II Clinical Trial for Advanced Ovarian Cancer is Open for Enrollment
|
